An extended-established drug with a various medical historical past is drawing new consideration for its potential position in treating an ultra-rare and life-threatening genetic dysfunction. Early findings counsel {that a} drugs first developed a long time in the past might tackle an surprising new position in treating Bachmann-Bupp syndrome (BABS), a devastating and ultra-rare situation with no established remedy. […]
